Carolyn D. Beaver's most recent trade in Medicinova Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medicinova Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 18,227 | 18,227 | - | - | Restricted Stock Units | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 12,141 | 23,575 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 12,141 | 0 | - | - | Restricted Stock Units | |
| Medicinova Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,500 | 24,500 | - | - | Stock Option (Right to Buy) | |
| Sonendo Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2024 | 200,000 | 262,798 | - | 0 | Common Stock | |
| Sonendo Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2024 | 200,000 | 262,798 | - | 0 | Common Stock | |
| Medicinova Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 12,141 | 12,141 | - | - | Restricted Stock Units | |
| Sonendo Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 32,520 | 32,520 | - | - | Stock Option (Right to Buy) | |
| Sonendo Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 25,316 | 62,798 | - | 0 | Common Stock | |
| Medicinova Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 9,170 | 9,170 | - | - | Restricted Stock Units | |
| Sonendo Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 49,586 | 49,586 | - | - | Stock Options (Right to buy) | |
| Sonendo Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 34,682 | 37,482 | - | 0 | Common Stock | |
| Medicinova Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 5,633 | 5,633 | - | - | Restricted Stock Units | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 2,696 | 0 | - | - | Restricted Stock Units | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 2,696 | 11,434 (0%) | 0% | 0 | Common Stock | |
| Sonendo Inc | Carolyn D. Beaver | Director | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 02 Nov 2021 | 2,800 | 2,800 | - | 12 | 33,600 | Common Stock |
| Medicinova Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 5,944 | 5,944 | - | - | Restricted Stock Units | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 2,696 | 8,738 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 2,696 | 2,696 | - | - | Restricted Stock Units | |
| Medicinova Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2020 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| MaxLinear Inc | Carolyn D. Beaver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 1,165 | 1,165 | - | - | Restricted Stock Units |